C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/50 (2006.01) A61K 31/47 (2006.01) A61K 31/55 (2006.01) C07D 215/52 (2006.01) C07D 221/18 (2006.01) C07D 401/02 (2006.01) C07D 401/04 (2006.01) C07D 401/12 (2006.01) C07D 405/04 (2006.01) C07D 409/04 (2006.01) C07D 409/12 (2006.01) C07D 417/04 (2006.01)
Patent
CA 2191352
NK3 receptor antagonists of formula (I) are useful in treating inter alia pulmonary disorders, CNS disorders and neurodegenerative disorders.
L'invention se rapporte à des antagonistes du récepteur NK¿3? de la formule (I) qui sont utiles dans le traitement, entre autres, des maladies pulmonaires, des troubles du SNC et des troubles neurodégénératifs.
Farina Carlo
Giardina Giuseppe Arnaldo Maria
Grugni Mario
Raveglia Luca Francesco
Gowling Lafleur Henderson Llp
Smithkline Beecham Farmaceutici S.p.a.
Smithkline Beecham S.p.a.
LandOfFree
Quinoline derivatives as tachykinin nk3 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives as tachykinin nk3 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as tachykinin nk3 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1971593